Consonance-HFW Acquisition Corp.

liquidatedU=S+1WW=S@11.50
SRZNSEC EDGARCIK: 0001824893|Consonance Life Sciences•Biopharmaceutical

Capital Structure & Economics

Trust Size$100,000,000
Unit Price$10.00
Warrant Coverage1/1
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

100% Warrant Inclusion
Public Trust Allocation$100,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedOct 9, 2020
Target AnnouncedApr 15, 2021
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanySurrozen, Inc.
  • SectorBiopharmaceutical
  • Announced Deal Size$200,000,000
  • Announcement Date2021-04-15

Board & Officers

  • Craig ParkerCEO
  • Gad SofferOfficer
  • Kevin LivingstonOfficer
  • Benny SofferOfficer
  • Jennifer Jarrett(2)
    Director

Advanced Structuring Terms

Target SectorsBiopharmaceutical

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction